Loading...
•
Mar 31, 2022
Pacira Q1 2022 Earnings Report
Reported preliminary net product sales for EXPAREL and iovera for April 2022.
Key Takeaways
Pacira BioSciences reported preliminary unaudited net product sales for EXPAREL and iovera° for April 2022. EXPAREL net product sales were $44.8 million, while iovera° net product sales were $1.1 million.
EXPAREL net product sales were $44.8 million for April 2022, compared to $43.1 million for April 2021.
EXPAREL average daily sales for April 2022 were 109 percent of April 2021.
Net product sales of iovera° were $1.1 million for April 2022, compared with $1.5 million for April 2021.
The company is not providing 2022 financial guidance due to continued uncertainty around COVID-19.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...